New Insights Into the Vitreous and Choroid
By Allen C. Ho, MD; and Robert L. Avery, MD
Researchers have developed an approach to restore vision using a component of green algae.
By Callan Navitsky, Associate Editor
Significant changes are expected in coming years.
By George A. Williams, MD
By Aron Shapiro and Ashley Lafond
David Barañano, MD, PhD; Leon Charkoudian, MD; Jorge Fortun, MD; Rahul Khurana, MD; and Jeremy Wolfe, MD
Strategies for performing independent surgery of the vitreous and retina.
By Yannek I. Leiderman, MD, PhD
By Andres Amaya Espinosa, MD; Gina Baron Mendoza, MD; Maria Alejandra Toro Millan, MD; and Natalia Camacho Espinosa, MD
Vitrectomy and subretinal rtPA are options to be considered.
By Gene W. Chen, MD; and Andrew A. Moshfeghi, MD, MBA
By Yasmin Poustchi, BA; Swathi Kaliki, MD; and Carol L. Shields, MD
By Pravin U. Dugel, MD
The technology is already in use for diagnosis and management of some conditions.
By J. Sebag, MD, FACS, FRCOphth, FARVO
Enhanced depth SD-OCT imaging opens a new frontier in understanding of the choroid.
By Peter K. Kaiser, MD
By Bruno Lumbroso, MD
Corneal entry site in aphakic eyes avoids risks of more posterior access.
By Vinit B. Mahajan, MD, PhD
The MC-500 Vixi laser is capable of any combination of red, green, and yellow wavelengths.
By Evangelia Papavasileiou, MD, FEBOphth; and Som Prasad MS, FRCSEd, FRCOphth, FACS
An understanding of the role of the immune system in AMD may lead to new therapeutic approaches.
By Victor L. Perez, MD
By Sirichai Pasadhika, MD; Eric B. Suhler, MD, MPH; and Emmett T. Cunningham, Jr., MD, PhD, MPH
Dr. Williams is a Partner at VitreoRetinal Surgery, PA, and an Assistant Clinical Professor of Ophthalmology at the University of Minnesota.
In obese patients with uncontrolled type 2 diabetes, 12 months of medical therapy plus bariatric surgery yielded greater glycemic control than medical therapy alone, according to a study in the emNew England Journal of Medicine... more >
Advanced Cell Technology Inc., announced that the Bascom Palmer Eye Institute in Miami has received institutional review board approval as a site for the company’s phase 1/2 clinical trial for dry AMD using human embryonic s... more >
Bausch + Lomb has announced that it will purchase Ista Pharmaceuticals, Inc., in a deal reported to be worth about $500 million. Under the terms to the agreement, which is expected to close in the second quarter of 2012, Bausch... more >
Intraocular injections of bevacizumab (Avastin, Genentech) administered every 6 weeks for 6 months improved visual acuity in patients with macular edema secondary to central retinal vein occlusion (CRVO), according to a study ... more >
Advertisement
The technology is already in use for diagnosis and management of some conditions.
By J. Sebag, MD, FACS, FRCOphth, FARVO
By Pravin U. Dugel, MD
Researchers have developed an approach to restore vision using a component of green algae.
By Callan Navitsky, Associate Editor
By Sirichai Pasadhika, MD; Eric B. Suhler, MD, MPH; and Emmett T. Cunningham, Jr., MD, PhD, MPH
Vitrectomy and subretinal rtPA are options to be considered.
By Gene W. Chen, MD; and Andrew A. Moshfeghi, MD, MBA